{
    "title": "112_s1995",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Medical Device Patient Safety Act''.\n\nSEC. 2. OVERSIGHT OF DEVICE RECALLS BY THE FOOD AND DRUG \n              ADMINISTRATION.\n\n    (a) Definitions.--In this Act:\n            (1) Commissioner.--The term ``Commissioner'' means the \n        Commissioner of Food and Drugs.\n            (2) Device.--The term ``device'' has the meaning given that \n        term in section 201(h) of the Federal Food, Drug, and Cosmetic \n        Act (21 U.S.C. 321(h)).\n            (3) Secretary.--The term ``Secretary'' means the Secretary \n        of Health and Human Services.\n    (b) Actions by Secretary.--To enhance the oversight by the Food and \nDrug Administration of device recalls, the Secretary of Health and \nHuman Services, acting through the Commissioner of Food and Drugs, \nshall carry out the activities described in this section.\n    (c) Assessment of Device Recall Information.--\n            (1) In general.--\n                    (A) Assessment program.--The Secretary shall \n                establish a program to routinely and systematically \n                assess--\n                            (i) information submitted to the Secretary \n                        pursuant to a device recall order under section \n                        518(e) of the Federal Food, Drug, and Cosmetic \n                        Act (21 U.S.C. 360h(e)); and\n                            (ii) information required to be reported to \n                        the Secretary regarding a correction or removal \n                        of a device under section 519(g) of such Act \n                        (21 U.S.C. 360i(g)).\n                    (B) Use.--The Secretary shall use the assessment of \n                information described under subparagraph (A) to \n                proactively identify strategies for mitigating health \n                risks presented by defective or unsafe devices.\n            (2) Design.--The program under paragraph (1) shall be \n        designed, at a minimum, to identify--\n                    (A) trends in the numbers and types of device \n                recalls;\n                    (B) the types of devices in each device class that \n                are most frequently recalled;\n                    (C) the causes of device recalls;\n                    (D) the length of time needed for a person subject \n                to a device recall to complete the recall;\n                    (E) the length of time needed for the Secretary to \n                terminate a device recall;\n                    (F) whether the Secretary has performed a device \n                recall audit check;\n                    (G) which persons have been subject to the most \n                device recalls; and\n                    (H) any other information as the Secretary \n                determines appropriate.\n    (d) Audit Check Procedures.--The Secretary shall clarify procedures \nfor conducting device recall audit checks to improve the ability of \ninvestigators to perform these checks in a consistent manner.\n    (e) Assessment Criteria.--The Secretary shall develop explicit \ncriteria for assessing whether a person subject to a recall order under \nsection 518(e) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. \n360h(e)) or to a requirement under section 519(g) of such Act (21 \nU.S.C. 360i(g)) has performed an effective correction or removal action \nunder such section 519(g).\n    (f) Termination of Recalls.--\n            (1) In general.--The Secretary shall document the basis for \n        the termination by the Food and Drug Administration of--\n                    (A) an individual device recall ordered under \n                section 518(e) of the Federal Food, Drug, and Cosmetic \n                Act (21 U.S.C. 360h(e)); and\n                    (B) the requirement on a manufacturer or importer \n                of a device to report any correction or removal action \n                for which a report is required to be submitted to the \n                Secretary under section 519(g) of such Act (21 U.S.C. \n                360i(g)).\n            (2) Publication.--\n                    (A) In general.--The Secretary shall, with respect \n                to each termination described in paragraph (1), publish \n                the documentation required under such paragraph not \n                later than 180 days after such termination.\n                    (B) Protection of confidential information or trade \n                secrets.--Before public disclosure of the documentation \n                under subparagraph (A), the Secretary shall delete from \n                the documentation the following:\n                            (i) Any information that constitutes trade \n                        secret or confidential commercial or financial \n                        information.\n                            (ii) Any personnel, medical, or similar \n                        information, including the serial numbers of \n                        implanted devices, which would constitute a \n                        clearly unwarranted invasion of personal \n                        privacy.\n\nSEC. 3. CONDITIONAL CLEARANCE OF CERTAIN MEDICAL DEVICES.\n\n    (a) In General.--Chapter V of the Federal Food, Drug, and Cosmetic \nAct (21 U.S.C. 351 et seq.) is amended by inserting after section 510 \nthe following:\n\n``SEC. 510A. CONDITIONAL CLEARANCE OF CERTAIN MEDICAL DEVICES.\n\n    ``(a) In General.--Notwithstanding any other provision of law, the \nSecretary may conditionally clear for introduction into interstate \ncommerce for commercial distribution a medical device intended for \nhuman use if such medical device is cleared pursuant to section 510(k).\n    ``(b) Postclearance Requirements.--As part of the conditional \nclearance under subsection (a), the Secretary may impose the following:\n            ``(1) The Secretary may restrict the sale, distribution, or \n        use of the device but only to the extent that the sale, \n        distribution, or use of the device may be restricted pursuant \n        to section 520(e).\n            ``(2) The Secretary--\n                    ``(A) may require continuing evaluation and \n                periodic reporting on the safety, effectiveness, and \n                reliability of the device for its intended use; and\n                    ``(B) shall, to the extent the Secretary makes a \n                requirement under subparagraph (A), state in the \n                clearance order the reason or purpose for such a \n                requirement and the number of patients to be evaluated \n                and the reports required to be submitted.\n            ``(3) The Secretary may require a prominent display in the \n        labeling of the device and in the advertising of warnings, \n        hazards, or precautions important for the device's safe and \n        effective use, including patient information such as \n        information provided to the patient on alternative modes of \n        therapy and on risks and benefits associated with the use of \n        the device.\n            ``(4) The Secretary--\n                    ``(A) may require maintenance of records that will \n                enable the applicant to submit to the Food and Drug \n                Administration information needed to trace patients if \n                such information is necessary to protect the public \n                health; and\n                    ``(B) shall, to the extent the Secretary makes the \n                requirement under subparagraph (A), require that the \n                identity of any patient be disclosed in records \n                maintained under the postclearance reporting \n                requirements only to the extent required for the \n                medical welfare of the individual, to determine the \n                safety or effectiveness of the device, or to verify a \n                record, report, or information submitted to the agency.\n            ``(5) The Secretary may require maintenance of records for \n        specified periods of time and organization and indexing of \n        records into identifiable files to enable the Food and Drug \n        Administration to determine whether there is reasonable \n        assurance of the continued safety and effectiveness of the \n        device.\n            ``(6) The Secretary may require submission of periodic \n        reports, at specified intervals, which reports shall comply \n        with the following:\n                    ``(A) Identify any of the following changes:\n                            ``(i) New indications for use of the \n                        device.\n                            ``(ii) Labeling changes.\n                            ``(iii) The use of a different facility or \n                        establishment to manufacture, process, or \n                        package the device.\n                            ``(iv) Changes in sterilization procedures.\n                            ``(v) Changes in packaging.\n                            ``(vi) Changes in the performance or design \n                        specifications, circuits, components, \n                        ingredients, principle of operation, or \n                        physical layout of the device.\n                            ``(vii) Extension of the expiration date of \n                        the device based on data obtained under a new \n                        or revised stability or sterility testing \n                        protocol.\n                            ``(viii) A change that does not affect the \n                        device's safety or effectiveness.\n                    ``(B) Contain a summary and bibliography of the \n                following information not previously submitted:\n                            ``(i) Unpublished reports of data from any \n                        clinical investigations or nonclinical \n                        laboratory studies involving the device or \n                        related devices and known to or that reasonably \n                        should be known to the applicant.\n                            ``(ii) Reports in the scientific literature \n                        concerning the device and known to or that \n                        reasonably should be known to the applicant. \n                        If, after reviewing the summary and \n                        bibliography, the Food and Drug Administration \n                        concludes that the agency needs a copy of the \n                        unpublished or published reports, the Food and \n                        Drug Administration shall notify the applicant \n                        that copies of such reports should be \n                        submitted.\n                    ``(C) Identify changes made pursuant to an \n                exception or alternative granted under section 801.128 \n                or 809.11 of title 21, Code of Federal Regulations.\n            ``(7) The Secretary may require batch testing of the \n        device.\n            ``(8) The Secretary may provide for any other requirements \n        determined by the Secretary to be necessary to provide \n        reasonable assurance, or continued reasonable assurance, of the \n        safety and effectiveness of the device.\n            ``(9) The Secretary may require device tracking as provided \n        under part 821 of title 21, Code of Federal Regulations.\n    ``(c) Rescission of Conditional Clearance.--The Secretary may \nrescind the conditional clearance of a medical device under subsection \n(a) if the Secretary determines that the conditions imposed on the \nclearance of the device described in subsection (b) have not been \nmet.''.\n    (b) Civil Monetary Penalties.--Section 303(f)(1)(A) of the Federal \nFood, Drug, and Cosmetic Act (21 U.S.C. 333(f)(1)(A)) is amended by \ninserting ``, or a regulation promulgated or an order issued to carry \nout this Act,'' after ``any person who violates a requirement of this \nAct''.\n    (c) Process for the Review of Device Applications.--Section \n737(8)(J) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. \n379i(8)(J)) is amended by inserting ``or required as a condition of \nclearance of a device under section 510A'' after ``Act''."
}